TipRanks
Go Ultimate55% OFF

Burcon Nutrascience (BNE0) Stock Price & Analysis

BNE0 Stock Chart & Stats

€0.57-€0.04(-5.79%)
At close: 1:00 AM GMT+1
€0.8€0.9€17 Sep14 Sep21 Sep6 Oct
Day’s Range
EUR 0.57 - EUR 0.57
52-Week Range
EUR 0.56 - EUR 1.60
Previous Close
EUR 0.61
Volume
N/A
Average Volume (3M)
83
Market Cap
EUR 7.81M
Enterprise Value
EUR 52.20M
Total Cash (Recent Filing)
EUR 866.46K
Total Debt (Recent Filing)
EUR 28.95M
Price to Earnings (P/E)
―
Beta
-0.02
Next Earnings
Nov 18, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

Rapid sequential and year-over-year revenue growth indicates improving commercial traction and expanding customer demand. If sustained, this growth can increase operating leverage, support capacity investment, and establish a stronger base for recurring revenue over the next several quarters.

Customer Adoption

Repeat purchases from 40 active customers provide evidence that Burcon’s ingredients are moving beyond evaluation into commercial use. This validation can support retention, broaden application adoption, and make future revenue growth more durable than one-time trial activity.

Scalable Product Portfolio

Commercial production across sunflower, pea, fava and canola proteins demonstrates product breadth and progress in scaling Burcon’s technology across applications. A diversified portfolio may improve customer relevance and create more avenues for growth as plant-protein demand develops.

Bears Say

Severe Unprofitability

Extremely negative gross, operating and net margins show that current revenue is not covering the cost of the business. Even with reported sales growth, the company must materially improve unit economics and operating efficiency before growth can translate into sustainable earnings.

Balance Sheet Stress

Negative equity combined with debt exceeding the asset base indicates a highly pressured capital structure and limited financial flexibility. This can constrain investment choices, increase dependence on financing, and leave the company more exposed if operating improvements take longer than expected.

Cash Burn And Financing Dependence

Persistent operating and free-cash-flow deficits mean Burcon is consuming cash while it scales, rather than funding expansion internally. Reliance on a sizeable convertible debenture raise increases execution and financing risk until the targeted transition to positive cash flow is achieved.

Burcon Nutrascience News

BNE0 FAQ

What was Burcon Nutrascience’s price range in the past 12 months?
Burcon Nutrascience lowest stock price was €0.56 and its highest was €1.60 in the past 12 months.
What is Burcon Nutrascience’s market cap?
Burcon Nutrascience’s market cap is €7.81M.
When is Burcon Nutrascience’s upcoming earnings report date?
Burcon Nutrascience’s next earnings report is estimated for Nov 18, 2026 (not yet confirmed), which is in 16 days.
How were Burcon Nutrascience’s earnings last quarter?
Burcon Nutrascience released its earnings results on Aug 12, 2026. The company reported -€0.192 earnings per share for the quarter, missing the consensus estimate of -€0.045 by -€0.147.
Is Burcon Nutrascience overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Burcon Nutrascience pay dividends?
Burcon Nutrascience does not currently pay dividends.
What is Burcon Nutrascience’s EPS estimate?
Burcon Nutrascience’s EPS estimate is -0.11.
How many shares outstanding does Burcon Nutrascience have?
Burcon Nutrascience has 12,692,942 shares outstanding.
What happened to Burcon Nutrascience’s price movement after its last earnings report?
Burcon Nutrascience reported an EPS of -€0.192 in its last earnings report, missing expectations of -€0.045. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Burcon Nutrascience?
Currently, no hedge funds are holding shares in DE:BNE0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology